- Home
- GLPG vs UPWK Comparison
GLPG vs UPWK Comparison
Compare GLPG & UPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLPG | UPWK |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | Belgium | United States |
| Employees | 704 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | GLPG | UPWK |
|---|---|---|
| Price | $32.47 | $12.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $36.50 | $22.33 |
| AVG Volume (30 Days) | 90.9K | ★ 4.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.84 |
| Revenue | N/A | ★ $787,784,000.00 |
| Revenue This Year | N/A | $9.10 |
| Revenue Next Year | N/A | $13.60 |
| P/E Ratio | ★ N/A | $14.76 |
| Revenue Growth | N/A | ★ 2.40 |
| 52 Week Low | $22.59 | $11.13 |
| 52 Week High | $37.78 | $22.84 |
Technical Indicators
Market Signals| Indicator | GLPG | UPWK |
|---|---|---|
| Relative Strength Index (RSI) | 39.01 | 30.72 |
| Support Level | $32.07 | $11.46 |
| Resistance Level | $33.56 | $13.89 |
| Average True Range (ATR) | 0.80 | 0.59 |
| MACD | -0.16 | 0.14 |
| Stochastic Oscillator | 0.00 | 8.92 |
Price Performance
Historical ComparisonAbout GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.